Literature summary for 3.4.24.B9 extracted from

Carl-McGrath, S.; Lendeckel, U.; Ebert, M.; Roessner, A.; Roecken, C.
The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer (2005), Int. J. Oncol., 26, 17-24.

Application

Application	Comment	Organism
medicine	all three enzymes ADAM9, ADAM12, and ADAM15 are significantly upregulated in gastric cancer compared to non-neoplastic foveolar epithelium. Anti-ADAM9 and anti-ADAM15 antibodies inhibit cell growth	Homo sapiens

Organism	UniProt	Comment	Textmining
Homo sapiens	-	patients with gastric cancer	-

Source Tissue	Comment	Organism	Textmining
gastric cancer cell	-	Homo sapiens	-

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)